ACADIA Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACAD and other ETFs, options, and stocks.

About ACAD

ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis.

CEO

Catherine Owen Adams

CEOCatherine Owen Adams

Employees

654

Employees654

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1993

Founded1993

Employees

654

Employees654

ACAD Key Statistics

Market cap

2.87B

Market cap2.87B

Price-Earnings ratio

12.49

Price-Earnings ratio12.49

Dividend yield

—

Dividend yield—

Average volume

2.25M

Average volume2.25M

High today

—

High today—

Low today

—

Low today—

Open price

$17.13

Open price$17.13

Volume

0.00

Volume0.00

52 Week high

$20.68

52 Week high$20.68

52 Week low

$13.40

52 Week low$13.40

ACAD News

Simply Wall St 6d

ACADIA Pharmaceuticals Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

ACADIA Pharmaceuticals Inc. ( ) just released its first-quarter report and things are looking bullish. ACADIA Pharmaceuticals beat earnings, with revenues hitti...

TipRanks 7d

ACADIA Pharmaceuticals Reports Strong Q1 Earnings Growth

ACADIA Pharmaceuticals Inc. ((ACAD)) has held its Q1 earnings call. Read on for the main highlights of the call. The recent earnings call of ACADIA Pharmaceuti...

Analyst ratings

60%

of 20 ratings

Buy

60%

Hold

35%

Sell

People also own

Based on the portfolios of people who own ACAD. This list is generated using Robinhood data, and it’s not a recommendation.